{
  "docId": "019de076-9336-7344-93bc-154185328b25",
  "docSlug": "edea36d6b00ed662cafb2da1a03c41ae",
  "documentTitle": "BenevolentAI | Investor Conference Presentation Deck | 22 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 22,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a timeline-like structure to list six distinct value propositions.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-9336-7344-93bc-154185328b25/11",
  "deckHref": "/decks/019de076-9336-7344-93bc-154185328b25",
  "deckJsonHref": "/decks/019de076-9336-7344-93bc-154185328b25.json",
  "deckAnchorHref": "/decks/019de076-9336-7344-93bc-154185328b25#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.25,
        "x": 0.68,
        "y": 0.15
      },
      "kind": "image",
      "text": "Visual representations of the six investment highlights including platform architecture, market growth, pipeline assets, and partner logos.",
      "attrs": null,
      "subkind": "infographic",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c27b3c6d-659c-4979-8bbf-428c1951a587",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.6,
        "x": 0.07,
        "y": 0.2
      },
      "kind": "list",
      "text": "Pioneer & leader in AI-augmented drug discovery; Clear, growing market demand; Business model offers multiple routes for revenue; Leading End-to-End Drug Discovery solutions; High potential Preclinical & Clinical Development Pipeline; New expansion opportunity",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ef42e81d-ca53-4814-98c0-725ac2dbdc8d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.35,
        "x": 0.05,
        "y": 0.06
      },
      "kind": "title",
      "text": "Key investment highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab2261ac-323d-4601-a0ee-802d85ec0e93",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "ff12ccee-98fa-442d-ba52-f152845e0505",
      "evidence": "list/bullet: Pioneer & leader in AI-augmented drug discovery; Clear, growing market demand; Business model offers multiple routes for revenue; Leading End-to-End Drug Discovery solutions; High potential Preclinical & Cli",
      "confidence": 0.6
    }
  ],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "a2403044-e3ac-4728-8978-f1f287e2194e",
      "evidence": "The slide presents key points in a structured vertical list format.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}